Your browser doesn't support javascript.
loading
Omega-3 Fatty Acids and PPARgamma in Cancer.
Edwards, Iris J; O'Flaherty, Joseph T.
Afiliación
  • Edwards IJ; Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.
PPAR Res ; 2008: 358052, 2008.
Article en En | MEDLINE | ID: mdl-18769551
ABSTRACT
Omega-3 (or n-3) polyunsaturated fatty acids (PUFAs) and their metabolites are natural ligands for peroxisome proliferator receptor activator (PPAR)gamma and, due to the effects of PPARgamma on cell proliferation, survival, and differentiation, are potential anticancer agents. Dietary intake of omega-3 PUFAs has been associated with a reduced risk of certain cancers in human populations and in animal models. In vitro studies have shown that omega-3 PUFAs inhibit cell proliferation and induce apoptosis in cancer cells through various pathways but one of which involves PPARgamma activation. The differential activation of PPARgamma and PPARgamma-regulated genes by specific dietary fatty acids may be central to their distinct roles in cancer. This review summarizes studies relating PUFAs to PPARgamma and cancer and offers a new paradigm relating an n-3 PUFA through PPARgamma to the expression of the cell surface proteoglycan, syndecan-1, and to the death of cancer cells.

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: PPAR Res Año: 2008 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: PPAR Res Año: 2008 Tipo del documento: Article País de afiliación: Estados Unidos